Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDOSTAURIN vs MILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIDOSTAURIN vs MILNACIPRAN: Safety Overview

Metric MIDOSTAURIN MILNACIPRAN
Total FAERS Reports 2,993 1,392
Deaths Reported 694 120
Death Rate 23.2% 8.6%
Hospitalizations 918 274
Average Patient Age 53.3 yrs 54.8 yrs
% Female Patients 45.5% 82.6%
FDA Approval Date Apr 28, 2017 Apr 22, 2016
Manufacturer Novartis Pharmaceuticals Corporation Cardinal Health 107, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription